Surrogate markers are not 'one-size-fits-all' | Cleveland Clinic Journal of Medicine
Pulsatile energy consumption as a surrogate marker for vascular afterload improves with time post transcatheter aortic valve replacement in patients with aortic stenosis | Hypertension Research
Endpoints for geroscience clinical trials: health outcomes, biomarkers, and biologic age | SpringerLink
Example 1: Continuous Surrogate Marker • OptimalSurrogate
Surrogate Endpoints and Biomarkers | Basicmedical Key
PPT - Surrogate Markers and its role in the Drug Development Process PowerPoint Presentation - ID:533855
Surrogate Markers of Chronic Allograft Nephropathy in Man - ppt download
UNDERSTANDING SCIENCE: SURROGATE MARKERS | Evidence Based Training
surrogate markers - List of Frontiers' open access articles
Reasons for failure of surrogate markers in predicting endpoints.... | Download Scientific Diagram
Surrogate marker evaluation when data are small, large, or very large (Geert Molenberghs)
MRI as a surrogate marker for clinical outcomes in multiple sclerosis | Personalized Management of Multiple Sclerosis
Controlling HgBA1C with Medications Does not Make Diabetes Disappear - It Lowers the Surrogate Marker HgBA1C - APIM
FDA Facts: Biomarkers and Surrogate Endpoints | FDA
32132-1.fp.png "LEFT ATRIAL STRAIN AS A SURROGATE MARKER OF ATRIAL CHAMBER STIFFNESS | Journal of the American College of Cardiology")
LEFT ATRIAL STRAIN AS A SURROGATE MARKER OF ATRIAL CHAMBER STIFFNESS | Journal of the American College of Cardiology
REBEL Cast Episode 1: Clinically Important Biphasic Anaphylaxis & Total Lymphocyte Count as a Surrogate Marker for CD4 - REBEL EM - Emergency Medicine Blog
Copeptin, a surrogate marker for vasopressin, is associated with chronic kidney disease progression in patients with diabetes mellitus (ZODIAC-33) - Media Centre | EASD
2 Review: Evaluating and Regulating Biomarker Use | Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease |The National Academies Press
What Do We Know About Surrogate Markers and Disease Outcomes? (Slides with Transcript)
Cardiovascular surrogate markers and cardiometabolic therapeutics: a viewpoint learned from clinical trials on dipeptidyl peptidase-4 inhibitors | Cardiovascular Diabetology | Full Text
Surrogate endpoints: a regulatory review
Defining vitamin D deficiency, using surrogate markers – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science hub.
Noninvasive Testing and Surrogate Markers in Invasive Fungal Diseases
